Assoc Prof Dr. Muzaffer Sancı, tepecik education and research hospital, Turkey
Assoc. Prof. Dr. Muzaffer Sancı specializes in gynecological oncology, focusing on endometrioid-type endometrial carcinoma. His research delves into post-treatment quality of life, emphasizing sleep 🛌, fatigue 💤, and psychological well-being. Dr. Sancı conducted a cross-sectional study with 147 female patients, utilizing tools like PSQI, FAS, and BDI to explore correlations among these factors. His findings underscore the importance of integrated medical and psychological care in enhancing patient outcomes. Dr. Sancı advocates for multidisciplinary approaches to support long-term well-being and quality of life in cancer survivors.
Publication profile
Scopus
Research Focus
Assoc. Prof. Muzaffer Sancı’s research primarily focuses on gynecological oncology 🩺, with a special interest in the intersections of medical imaging and cancer pathology. His studies explore the role of magnetic resonance imaging (MRI) in distinguishing between different types of ovarian tumors, aiming to improve diagnostic accuracy and treatment planning. Additionally, he investigates rare cases like metastasis of endometrial cancer to the breast, contributing valuable insights into unusual disease presentations and management strategies. Dr. Sancı’s work not only enhances clinical understanding but also underscores the importance of advanced imaging technologies in oncological care.
Publication Top Notes
- Prognostic factors of adult granulosa cell tumors of the ovary: J Gynecol Oncol, 2024 🩺
- Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: J Obstet Gynecol Res, 2024 🩺
- Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Asia Pac J Clin Oncol, 2024 🩺
- Characteristics of patients with late recurrence endometrial cancer: J Cancer Res Ther, 2024 🩺
- Risk factors for omental metastasis and the effect of omentectomy on survival in type 2 endometrial cancer patients: Curr Probl Cancer, 2023 🩺
- The prognostic value of P53 index in predicting the recurrence of early low-risk endometrial cancer: J Obstet Gynecol Res, 2023 🩺
- Metastasis of endometrial cancer to breast: J Obstet Gynecol Res, 2023 🩺
- Prediction model for residual high-grade cervical intraepithelial lesions: Minerva Obstet Gynecol, 2023 🩺
- Prognostic value of lymph node features in stage IIIC endometrial adenocancer: J Cancer Res Ther, 2023 🩺
- Role of magnetic resonance imaging in differentiating mucinous ovarian carcinoma: Rev Assoc Med Bras, 2023 🩺
- Cited by 1